| Gaudet LA, Pillay J, Saba S, Zakaria D, Cheta N, Tan M, Vandermeer B, Hartling L. Risk of new diagnoses and exacerbations of chronic conditions after SARS-CoV-2 infection: a systematic update. Epidemiologic Reviews, Volume 48, Issue 1, Pages 1-17, January 2026. |
| Maguire, D., Kassam, I., Mathura, P., Turk, T., Pan, B., Hawkins, L., Al Hamarneh, Y. and Yacyshyn, E., 2026, August. Identifying and Supporting At-Risk Vasculitis Patients: Integrating Targeted Mental Health Screening and Psychology Referral into Rheumatology Care. In The Journal of Rheumatology (Vol. 53, No. Suppl 1, pp. 117-117). The Journal of Rheumatology. |
| Kraut R, Ono C, Garrison S, Kamal O, Doroshuk M, Vandermeer B, Amanna G, Babenko O. Does the Format of the Adult ADHD Self Report Scale Influence Screen-Positive Rates? A Randomization Controlle Trial in Primary Care. Frontiers in Psychiatry, 16:1646293. doi: 10.3389/fpsyt.2025.1646293. January 2026. |
| Seo, B., Dhanoa, A., Rider, N., Rioux, W., Viste, D., Pan, B., Al Hamarneh, Y. and Ghosh, S.M., 2026. Perceived impacts of Supervised Consumption Sites (SCS) on key service aspects and settings: Reports from Canadian National Questionnaire on Overdose Monitoring (CNQOM). International Journal of Drug Policy, 151, p.105216. |
| Yang, G., Pan, B., Lian, C., Zhou, X., Kong, L., Wang, Y. and Jiang, B. (2026) ‘One-shot weighted ensemble estimation for federated quantile regression: Optimal statistical guarantees under heterogeneous structured data’, Proceedings of the 43rd International Conference on Machine Learning, 30 April. |
| Pickett, B., Pan, B., Crawford, S., Schmölzer, G.M., McNeil, D.A., Soraisham, A.S., Shonoski, H., Aziz, K. and Law, B.H.Y., 2026. Clinical and Nonclinical Factors and Advanced Neonatal Resuscitation Interventions. JAMA Network Open, 9(4), p.e269923. |
| Seo, B., Rider, N., Viste, D., Rioux, W., Dhanoa, A., Vasquez, M., Pan, B. and Ghosh, S.M., 2026. Investigating the barriers to uptake and utilization of overdose response hotlines and apps: A study based on data from a national survey. Digital Health, 12, p.20552076261440969. |
| Al Hamarneh, Y.N., Ramrattan, D.A., Tsuyuki, R.T., Sullivan, K.W., Pan, B. and Simpson, S.H., 2026. What services do people seek when they visit a community pharmacy care clinic?. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 159(1), pp.59-69. |
| Ali S, Hudson S, Rajajopal M, Stinson JN, Gourlay K, Ma K, Candelaria P, Vandermeer B, Felkar B, Schreiner K, Proctor A, Hartling L. A Randomized Controlled Trial of Commercially Available Virtual Reality for Intravenous Canullatin-Related Distress in Children. Journal of Pediatrics, 288:114803 doi: 10.1016/j.jpeds.2025.11803. Epub ahead of print. PMID: 40962105, January 2026. |
| Rider, N., Seo, B., Viste, D., Rioux, W., Sedaghat, N., Pan, B., Al Hamarneh, Y.N., McCormack, G.R., Aghajafari, F., McDougall, L. and Ghosh, S.M., 2026. Attitudes towards supervised consumption sites and e-health overdose response interventions: development and reliability of the Canadian National Questionnaire on Overdose Monitoring (CNQOM). BMJ open, 16(1), p.e105751. |
| Galleguillos, D., Zhao, Y., Pan, B., Vandermeer, B., Zaidi, A., Al Hamarneh, Y.N., Sarna, J., Suchowersky, O., Curtis, J. and Sipione, S., 2025. Plasma gangliosides correlate with disease stages and symptom severity in Huntington’s disease carriers. medRxiv, pp.2025-03. |
| Rider, N., Seo, B., Viste, D., Rioux, W., Sedaghat, N., Pan, B., Al Hamarneh, Y.N., McCormack, G.R., Aghajafari, F., McDougall, L. and Ghosh, S.M., 2025. The development of a national bilingual cross-sectional questionnaire on attitudes towards supervised consumption sites and e-health overdose response interventions in Canada: The Canadian National Questionnaire on Overdose Monitoring (CNQOM). medRxiv, pp.2025-03. |
| Chu, N.Y., Yushko, L., Pan, B., Al Hamarneh, Y.N., Watson, K.E., Tsuyuki, R.T. and Smyth, P., 2025. Evaluating the impact of systematic reporting of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a randomized controlled trial. Multiple Sclerosis and Related Disorders, 99, p.106502. |
| Smith, J.D., Pan, B. and Keeling, S., 2025. Identifying the state of mental health care in Canadian adults with systemic lupus erythematosus. The Journal of Rheumatology, 52(11), pp.1115-1122. |
| Isley S, Johnson E, Corrick S, Dolgoy N, Vandermeer B, Tabert N, Pituskin E, Tandon P. The impact of mind-body internet and mobile based interventions on fatigue in adults living with chronic physical conditions: A systematic review and meta-analysis of randomized control trials. PLOS Digital Health, Volume 4, Issue 6, e0000878, June 2025. |
| Omkar A, Bertrand JK, Sadasivan C, Osness E, Vandermeer B, Ding X, Dennett L, Mansour J, Ezeugwu VE, Hyde A, Tandon P. Behaviour change techniques in eHealth interventions for older, frail, or sarcopenic adults: A systmatic review and meta-analysis. Digital Health, Volume 12, 1-20 12:20552076261473804. doi: 10.1177/20552076261473804 ecollections 2026. July 2026. |
| Clifford AH, Thai J, Yip A, Homik J, Vandermeer B, Kung JY, Tervaert JWC. Follow-up 18F-Flurodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Meta-analysis. Journal of Rheumatology, doi: 10.3899/jrhem 2026-0050, published ahead of print, July 2026. |
| Gerdes R, Roberts R, Jackson TD, Premji R, Deibert D, Choi C, Steer KJD, Bani-Fatemi A, Dennett L, Lytvyak E, Ferguson-Pell M, Tsuyuki R, Durand-Moreau Q, Gross DP, Hagtvedt R, Vandermeer B, Nowrouzi-Kia B, Straube S. Telehealth Treatments of Common Psychological Disorders: An Overview and Meta-analysis. Journal of Occupational Rehabilitation. doi: 10.1007/s10926-026-10406-7. Online ahead of print, May 2026. |
| Selzer AM, Davoodi PM, Klarenbach S, Lam NN, Smith T, Ackroyd A, Vandermeer B, Corradetti B, Dhaliwal A, Ferdinand S, Ikekekpolor D, Smith G, Bello AK, Wen K, Shojai S. The Multidisciplinary Support to Access living donor Kidney Transplant (MuST AKT) intervention: A Pilot Randomized Control Trial. Transplant International 39:15472. doi: 10.3389/ti 2026, 15472. February 2026. |
| Ma CH, Qi A, Gagnon L, Wang K, Sadasivan C, Ghimire A, Cooper M, Tungsanga S, Oguaju B, Vandermeer B, McAlister FA, Bello AK, Oudit GY. Therapy gaps for patients with heart failure and reduced kidney function: A prospective cohort study. ESC Heart Failure 2025; 12: 4431-441. DOI: 10.1002/ehf2.70008. November, 2025. |
| Pillay J, Gates A, Guitard S, Zakher B, Sim S, Vandermeer B, Hartling L. Screening for the prevention and early detection of cervical cancer: systmatic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care. Systematic Reviews, Volume 14, issue1 doi: 10.1186/s13643-025-02866-4. October 2025. |
| Jarab AS, Al-Qerem W, Mansour R, Jarab H, Abu Heshmeh SR, Jrab O, Elrefae A, Al Hamarneh YN, Al Meslamani AZ, Aburuz S. Factors associated with low-density lipoprotein control in outpatients with myocardial infarction: A hospital-based study. PLoS One. 2026 Jul 16;21(7):e0353521. doi: 10.1371/journal.pone.0353521. PMID: 42461800; PMCID: PMC13375025. |
| Ramrattan DA, Al Hamarneh YN, Tsuyuki RT, Simpson SH. Proposed ICD-10 framework for identifying emergency department visits that may be impacted by community pharmacy care clinics. Int J Clin Pharm. 2026 Jun;48(3):1058-1068. doi: 10.1007/s11096-026-02089-0. Epub 2026 Feb 26. PMID: 41746568; PMCID: PMC13176181. |
| Watson KE, Dsa K, Pan B, Al Hamarneh YN. Measuring pharmacist engagement: Development and preliminary validation and reliability of a pharmacist engagement questionnaire (POWER Engagement Framework). Res Social Adm Pharm. 2026 Sep;22(9):863-869. doi: 10.1016/j.sapharm.2026.05.001. Epub 2026 May 2. PMID: 42106227. |
| Jarab AS, Al-Qerem W, Jarab H, Jrab O, Elsherif R, Al Meslamani AZ, Kharaba Z, Al Hamarneh Y, Khdour M, Alsaleh NA, Aburuz S. Public knowledge, attitudes, and barriers to cancer screening in the UAE: a comprehensive assessment to inform screening practices. Front Public Health. 2026 Apr 7;14:1808218. doi: 10.3389/fpubh.2026.1808218. PMID: 42022826; PMCID: PMC13095672. |
| Aref H, Al Hamarneh Y, Kiang T, Yacyshyn E, Sadowski C. Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study. JMIR Res Protoc 2026;15:e76237. URL: https://www.researchprotocols.org/2026/1/e76237. DOI: 10.2196/76237 |
| Aref HAT, Al Hamarneh YN, Yacyshyn E, Kiang TKL, Sadowski CA. Exploring Clinicians' Determinants of Participation in Medical Cannabis Decision Making with Older Adults Experiencing Arthritis: A Qualitative Descriptive Study. MDM Policy Pract. 2026 May 21;11(1):23814683261444057. doi: 10.1177/23814683261444057. PMID: 42181610; PMCID: PMC13195212. |
| Jarab AS, Al Meslamani AZ, Al-Qerem W, Jarab H, Ali Mohammed EM, Mohamed Moustafa HA, Naser AY, Al Hamarneh YN, Aburuz S. Job satisfaction and its demographic, occupational, and mental health determinants among community pharmacists. PLoS One. 2026 Feb 12;21(2):e0341726. doi: 10.1371/journal.pone.0341726. PMID: 41678469; PMCID: PMC12900340. |
| Jarab AS, Al-Qerem W, Alzoubi KH, Abdi FM, Abu Heshmeh S, Mukattash T, Al Hamarneh YN, Eberhardt J. Community Pharmacists’ Awareness, Attitudes, Readiness, and Perceived Barriers to Adopting 3D Printing Technology: A Cross-Sectional Study in the UAE, International Journal of Clinical Practice, 2026, 1988421, 11 pages, 2026. https://doi.org/10.1155/ijcp/1988421 |
| Jarab AS, Al Meslamani AZ, Al-Qerem W, Alyafeai H, Al Hamarneh YN, Eberhardt J. Integrating Large Language Models Into UAE Community Pharmacies: Pharmacists' Perspectives on Benefits, Concerns, and Implementation Barriers. Int J Telemed Appl. 2026 Jan 14;2026:8034289. doi: 10.1155/ijta/8034289. PMID: 41542144; PMCID: PMC12800738. |
| Zaki M, O’Sullivan C, Barrett E, Mirzai N, Thornton H, Al Hamarneh YN, Bermingham M. Evaluation of Cardiovascular Risk Factor Control Among People with Diabetes in the Community Pharmacy Setting—A Descriptive Observational Study. Diabetology. 2025; 6(10):107. https://doi.org/10.3390/diabetology6100107 |
| Sunner S, Jones B, Jones CA, Al Hamarneh YN, Sadowski C, Maksymowych WP, Yacyshyn EA. Age-related disparities in biologic therapy initiation among rheumatoid arthritis patients: Insights from a large retrospective cohort study. Clin Rheumatol. 2025 Oct;44(10):3847-3855. doi: 10.1007/s10067-025-07615-5. Epub 2025 Aug 12. PMID: 40789975. |
| d'Entremont-Harris M, Ramsey TD, MacNabb K, Murphy A, Bishop A, Isenor JE, Kelly DV, Al Hamarneh YN, Lee M, Ferguson A, Furlotte K, Woodill L, Hatchette T, Wilby KJ. Implementation and acceptance of pharmacists' prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). Can Pharm J (Ott). 2025 Aug 22;158(5):302-311. doi: 10.1177/17151635251355277. PMID: 40881659; PMCID: PMC12373644. |
| Clapham E, Carmichael S, Picone D, Schutte A, Slater K, Stevens J, Nelson M, Schlaich M, Tsuyuki R, Climie R, Stergiou G, Campbell N, Chapman N. How and why do Australians obtain blood pressure devices for use at home? A mixed-methods study revealing health literacy responsive ways to support this self-management behaviour. Health Literacy and Communication Open 2025; 3(1): 2594869. https://doi.org/10.1080/28355245.2025.2594869 |
| Liu S*, Tadrous M, Tsuyuki. Measuring What Matters: Introducing Pharmacy-Sensitive Quality Indicators (PSQIs). A framework to measure and demonstrate pharmacist impact (Editorial). Can Pharm J (Ott) 2026;159(1): 1-4. DOI:10.3138/cpj-2025-1028 |
| and, Liu S*, Tadrous M, Tsuyuki. Measuring What Matters: Pharmacy-Sensitive Quality Indicators (PSQIs) Evidence Brief. Can Pharm J (Ott) 2026;159(1): 6-7. DOI:10.3138/cpj-2025-1028-Ed-Brief |
| Nkunu V*, Campbell L, Tsuyuki RT, Bello AK, Ringrose J. Are ACE Inhibitors Effective in the Treatment of Hypertension in Black Patients? Can J Cardiol Open 2026:1-18. https://doi.org/10.1016/j.cjco.2026.01.011 |
| Tsuyuki RT, Gibson P, Ringrose J. Hypertension [internet]. Book chapter in CPS: Therapeutic Choices. Canadian Pharmacists Association, January, 2026. Available from: https://cps.pharmacists.ca. Subscription required. |
| Shields M*, McAusland L, Heintz M, Rittenbach K, Tsuyuki R, Box A, Emery J, Zwicker J, Arnold P, Newton A, Bousman CA. Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents (PGx-GAP): Study Protocol for a Randomized Controlled Trial. J Pers Med 2026;16:125. https://doi.org/10.3390/jpm16020125 |
| Rosenthal M, Austin Z, Hoti, K, Tsuyuki RT. AI in pharmacy practice: Devolutionary or evolutionary? (Editorial). Can Pharm J (Ott) 2026; 159(3): 149-153. https://doi.org/10.3138/cpj-26- |
| Desbiens V*, Wong G*, Liu S*, Chu NY, Watson KE, Smyth P, Tsuyuki RT. Patient Experiences with Systematically-Administered Patient-Reported Outcome Measures in Multiple Sclerosis. MS and Related Disorders 2026;110:107201. doi:10.1016/j.msard.2026.10720 |
| Ivensky V, Hundemer GL, Leung AA, Tsuyuki RT, Goupil R. Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study. Can J Cardiol 2026; xx: xx-xx. https://doi.org/10.1016/j.cjca.2026.04.034 |
| Smigorowsky MJ*, Tsuyuki RT. The Effect of Nurse Practitioner-Led Care on Health-Related Quality of Life in Adult Patients with Atrial Fibrillation – A Randomized Controlled Trial. Can J Cardiol Open 2026, in press (April 7, 2026). https://doi.org/10.1016/j.cjco.2026.03.018 |
| Tsuyuki RT, Boivin M, Liu S*. The time for the evolution of pharmacy care plans is now: A framework for pharmacist-led, patient-centred CARES Pathways. Can Pharm J (Ott) 2026; 159(Suppl 1):1S-11S. DOI:10.3138/cpj-25-0130_tsuyuki |
| Makedenge S*, Tsuyuki RT, Kippenhuck GT, Lee TA. The acceptability of pharmacy-based blood pressure screening in Newfoundland and Labrador: Insights from a patient-oriented survey. Can Pharm J (Ott) 2026;159(Suppl 2):S3-S10. DOI:10.3138/cpj-25- |
| Coombs SD, Young SW, Tsuyuki RT, Lee TA. Community-based blood pressure screening in Newfoundland and Labrador: Results from the 2024 May Measurement Month campaign. Can Pharm J (Ott) 2026;159(Suppl 2):S11-S19. DOI:10.3138/cpj-25-0078 |
| Makedenge S*, Tsuyuki RT, Kippenhuck GT, Lee TA. “It was easy to sit down and chat with the pharmacist”: Patients’ experiences with pharmacy-based blood pressure screening. Can Pharm J (Ott) 2026;159(Suppl 2):S20-S29. DOI:10.3138/cpj-25-0080 |
| Turgeon R, Hawkins NM, Tsuyuki RT, Virani S, Blitz S. Pharmacist-led intervention for Optimal Heart Failure Medications: A pilot randomized controlled trial. Can Pharm J (Ott) 2026;159(4):1-12. DOI:10.3138/cpj-25-0134 |
| Rosenthal M, Austin Z, Tsuyuki RT, Hoti K. AI in pharmacy practice: Is it a doomsday or a dream pill? (Editorial) Can Pharm J (Ott) 2026;159(4):1-6. DOI:10.3138/cpj-26-0428 |
| Babione J, Gil SA, Okemeziem CP, Palechuk T, Watson K, Robertshaw S, Verdin N, McBrien K, Campbell DJ, Tsuyuki RT, Pannu N, James MT, Donald M. Using Human-Centered Design and Development to Create a Digital Sick Day Medication Guidance Application for People With Diabetes, Cardiovascular Disease, or Chronic Kidney Disease: Mixed Methods Study. JMIR Form Res 2025;9:e772 |
| Barry AR, Mattarollo E*, Tsuyuki RT. Should all pharmacies have an automated external defibrillator? Can Pharm J (Ott) 2025;(Suppl1):2S-5S. DOI: 10.1177/171516352513825 |
| Mattarollo E*, Tsuyuki RT, Barry AR. Pharmacies and automated external defibrillators: A literature review. Can Pharm J (Ott) 2025;158(Suppl 1):6S-8S. DOI: 10.1177/171516352513825 |
| Barry AR, Tsuyuki RT. The landscape of automated external defibrillators in pharmacies: a preliminary survey. Can Pharm J (Ott) 2025;(Suppl 1):9S-11S. DOI: 10.1177/17151635251382588 |
| Tsuyuki RT, Barry AR. Pharmacists’ experience with automated external defibrillators. Can Pharm J (Ott) 2025;(Suppl 1):12S-14S. DOI: 10.1177/17151635251382591 |
| Tadrous M, Liu S*, Tsuyuki RT. Why pharmacy practice needs quality indicators (Editorial). Can Pharm J (Ott) 2025;158(6):331-337. DOI: 10.1177/17151635251384474 |
| Liu S*, Wong G*, Mavi P*, Gysel SC*, Burton D*, Monteiro N, Durocher D, Sharma AM, Tsuyuki RT. Factors contributing to non-persistence of glucagon-like peptide-1 agonists: a cross-sectional study. Obesity Med 2026;59:1000674. https://doi.org/10.1016/j.obmed.2025.100067 |
| Tsuyuki RT, Gysel SC*, Lee TA, Osasu YM, Poulter NR, Rodilla E. A hyper-opportunity for pharmacy (Editorial). Can Pharm J (Ott) 2025;158(4):183-185. DOI: 10.1177/1715163525134241 |
| Van der Linden L, Beavers C, Forsyth P, Vandenbriele C, Tsuyuki RT, Karapinar-Carkit F, Van Aelst L. Effects of pharmacist care on hospitalizations in heart failure across outpatient and inpatient settings: A systematic review and meta‐analysis. Br J Clin Pharmacol 2025; 1-10. DOI: 10.1002/bcp.70261. |
| Hall JJ, Tong H*, Watson KE*, Tsuyuki RT, Biggs C, Charrois TL. Navigating the influence of professional abstinence on pharmacy students: Observations and solutions from their perspective. Can Pharm J (Ott) 2025;158(3): 150-160. https://doi.org/10.1177/17151635241306458 |
| Watson KE*, Thomas IM, Patey AM, Robertshaw S, Moffat K, Tsuyuki RT, Grimshaw J. A Qualitative Study Exploring Women’s Understanding and Experiences of Managing Hypertension in Primary Care. Can J Cardiol Open 2025:1-9. DOI: 10.1016/j.cjco/2025.07.016 |
| Tonin FS, Tsuyuki RT, Fernandez-Llimos F, Garcia-Cardenas V, Laufs U, Schulz M. The role of pharmacists in the management of patients with atrial fibrillation: A systematic review and meta-analysis. Can Pharm J (Ott) 2025;158(6):351-367. DOI:10.1177/17151635251365148 |
| Gastens V*, Tancredi S, Bonnan D, Kiszio B, Del Giovane C, Tsuyuki RT, Paradis G, Chiolero A, Guénette L, Santschi V. Pharmacist interventions to improve hypertension management among patients with diabetes: a systematic review and meta analysis of randomized controlled trials. BMC Health Services Research 2025;25:1268. https://doi.org/10.1186/s12913-025-13461-7 |
Watson KE, Dsa K, Pan B, Al Hamarneh YN. Measuring pharmacist engagement: Development and preliminary validation and reliability of a pharmacist engagement questionnaire (POWER Engagement Framework). Research in Social and Administrative Pharmacy 2026;22(9):863–9.https://doi.org/10.1016/j.sapharm.2026.05.001.
|
| Turk T, Watson K, Aref H, Patel D, Jones A, Olson J, et al. The development of a cannabis risk assessment tool for patients with rheumatologic conditions: a Delphi study. Clin. Rheumatol. 2026;45:1971–9.10.1007/s10067-025-07807-z. |
| Arakawa N., Egawa T., Watson KE. Mobilizing and adapting pharmacy services for disaster response: learning from the Japanese mobile pharmacy model. Journal of Pharmaceutical Health Services Research, 2026;17(2) |
| Arakawa N, Namata C, Kobayashi E, Mamiya K, Irie T, Egawa T, et al. Navigating the Generosity of Medicines (Gen-MED): Characterizing the complex relationships of medication donations in Japan through stakeholder and social network analysis (ACCEPTED). Front Public Health 2026 |
| Watson KE, Thomas IM, Patey AM, Robertshaw S, Moffat K, Tsuyuki RT, et al. A qualitative study exploring women’s understanding and experiences of managing hypertension in primary care. CJC Open 2025;7(12):1629–37 |
| Watson KE, Schindel TJ, Meilianti S, Tsuyuki RT, Al Hamarneh YN. An international portrait of pharmacists' professional role identities: A Q-methodology innovative study. Exploratory Research in Clinical and Social Pharmacy 2025;19:100616 |
|
| Zhang JR, Yeung RO, Manca DP, Singh P, Olu-Jordan I, Perry T, Rahim G, Hagen EM, Lau D. The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort. Diabetes Obes Metab. 2026 Oct;28(10):9691-9694. doi: 10.1111/dom.71048. Epub 2026 Jun 30. PMID: 42381345; PMCID: PMC13538816. (acknowledgement) |
| Zhang JR, Singh P, Yeung RO, Manca DP, Perry T, Olu-Jordan I, Rahim G, Hagen EM, Lau D. Factors Associated with HbA1c-Lowering in a Randomized Trial of Continuous Glucose Monitoring in Adults with Non-Insulin-Treated Diabetes: An Observational Analysis. Can J Diabetes. 2026 Sep 30:S1499-2671(26)00370-9. doi: 10.1016/j.jcjd.2026.09.007. Epub ahead of print. PMID: 42815715.(acknowledgement) |
| Osaki, Y., Olson, J.L., Morhart, M.J., Curran, M.W., Zochodne, D.W., Chan, K.M. and the Central and Northern Alberta Peripheral Nerve Injury Research Consortium (2026), Conditioning Electrical Stimulation for Patients with Moderate or Severe Carpal Tunnel Syndrome: Double Blinded Randomized Controlled Trial. Ann Neurol, 99: 1251-1262. https://doi.org/10.1002/ana.78155 (acknowledgement) |